Polymorphisms Associated with Adalimumab and Infliximab Response in Moderate-To-Severe Plaque Psoriasis - Concepedia

Concepedia

Publication | Open Access

Polymorphisms Associated with Adalimumab and Infliximab Response in Moderate-To-Severe Plaque Psoriasis

DOI Full Paper Access

26

Citations

42

References

2017

Year

María C. Ovejero‐Benito, Rocío Prieto‐Pérez, Mar Llamas‐Velasco, Ester Muñoz‐Aceituno, Alejandra Reolid, Miriam Saiz‐Rodríguez, Carmen Belmonte, Manuel Román, Dolores Ochoa, María Talegón,

Pharmacogenomics

Abstract

Nevertheless, these biomarkers should be validated in large-scale studies before implementation in clinical practice.

References

	Year	Citations

Page 1